Nocturnal intraocular pressure (IOP) profiling has shown that the peak IOP usually occurs at night, particularly in patients ...

According to IQVIA, the product had US sales of approximately USD 111.6 million for the twelve months ending 2023.

Gland Pharma receives USFDA approval for Latanoprost Ophthalmic Solution, strengthening its position in the US pharmaceutical ...

Latanoprost Ophthalmic Solution is used for treatment of high eye pressure, or intraocular pressure (IOP) in patients with ...

The global glaucoma treatment market is projected to grow from USD 5.7 billion in 2022 to USD 8.0 billion by 2033, at a CAGR ...

Results from the NCX 470 Phase 3b Whistler Mechanism of Action trial expected in Q1 2025 ...

Glaucoma is one of the leading causes of preventable blindness in the U.S. In general, glaucoma occurs when pressure builds up in the eye and causes damage to the optic nerve. The optic nerve is like ...

While I hadn't experienced burns in the traditional sense, the condition caused chemical-like burns. Over more than 60 ...

A recent study has raised concerns about a commonly prescribed class of blood pressure medications known as Calcium Channel ...

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, United States ...

High blood pressure, or hypertension, is often called a “silent killer” because it doesn’t always have obvious symptoms.

A polygenic risk scoring system can predict 2 key glaucoma risk factors, potentially guiding the application of more intensive early treatments. A polygenic risk scoring system can help predict ...